CPC A61K 8/64 (2013.01) [A61K 8/86 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61P 17/02 (2018.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); C07K 1/061 (2013.01); C07K 4/10 (2013.01); C07K 7/06 (2013.01)] | 22 Claims |
1. A compound of formula (I):
| ||||||||||
its stereoisomers and/or its cosmetically or pharmaceutically acceptable salts, wherein:
AA1 is Phe;
AA2 is Trp;
AA3 is selected from the group consisting of Met, Leu and Ile;
AA4 is selected from the group consisting of Lys, Arg and Gln;
AA5 is Arg;
AA6 is Lys;
AA7 is selected from the group consisting of Arg, Lys and His;
AA8 is selected from the group consisting of Val, Ile, Leu and Met; and
AA9 is Pro;
W, X, Y and Z are each independently an amino acid;
m, n, p and q are each independently 0 or 1;
m+n+p+q is less than or equal to 2;
R1 is selected from the group consisting of H, a polymer derived from polyethylene glycol, a non-cyclic aliphatic group, alicyclyl, heterocyclyl, heteroarylalkyl, aryl, aralkyl and R5—CO—, wherein R5 is selected from the group consisting of H, a non-cyclic aliphatic group, alicyclyl, aryl, aralkyl, heterocyclyl and heteroarylalkyl;
R2 is selected from the group consisting of —NR3R4, —OR3, —SR3, wherein R3 and R4 are independently selected from a group consisting of H, a polymer derived from polyethylene glycol, a non-cyclic aliphatic group, alicyclyl, heterocyclyl, heteroarylalkyl, aryl and aralkyl; and
R1 and R2 are not amino acids.
|